1-3 of 3
Yoshio Kuwayama
Close
Sort by
Journal Articles

Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo

Chie Nishioka, Takayuki Ikezoe, Jing Yang, Atsushi Miwa, Taizo Tasaka, Yoshio Kuwayama, Kazuto Togitani, H. Phillip Koeffler, Akihito Yokoyama
Journal: Blood
Blood (2008) 111 (10): 5086–5092.
https://doi.org/10.1182/blood-2007-06-098079
Published: 2008
Includes: Supplemental data
Journal Articles

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

Jing Yang, Takayuki Ikezoe, Chie Nishioka, Taizo Tasaka, Ayuko Taniguchi, Yoshio Kuwayama, Naoki Komatsu, Kentaro Bandobashi, Kazuto Togitani, H. Phillip Koeffler, Hirokuni Taguchi, Akihito Yokoyama
Journal: Blood
Blood (2007) 110 (6): 2034–2040.
https://doi.org/10.1182/blood-2007-02-073700
Published: 2007
Journal Articles

ZM447439, a Novel Aurora Kinase Inhibitor, Induces Growth Arrest and Apoptosis of Human Leukemia Cells.

Takayuki Ikezoe, MD, Chie Nishioka, Taizo Tasaka, MD, Ayuko Taniguchi, MD, Naoki Komatsu, MD, Yoshio Kuwayama, MD, Kazuto Togitani, MD, H. Phillip Koeffler, MD, Hirokuni Taguchi, MD
Journal: Blood
Blood (2006) 108 (11): 1990.
https://doi.org/10.1182/blood.V108.11.1990.1990
Published: 2006